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Abstract
Background: Host defense peptides are a critical component of the innate immune system. Human alpha-
and beta-defensin genes are subject to copy number variation (CNV) and historically the organization of
mouse alpha-defensin genes has been poorly defined. Here we present the first full manual genomic
annotation of the mouse defensin region on Chromosome 8 of the reference strain C57BL/6J, and the
analysis of the orthologous regions of the human and rat genomes. Problems were identified with the
reference assemblies of all three genomes. Defensins have been studied for over two decades and their
naming has become a critical issue due to incorrect identification of defensin genes derived from different
mouse strains and the duplicated nature of this region.
Results: The defensin gene cluster region on mouse Chromosome 8 A2 contains 98 gene loci: 53 are
likely active defensin genes and 22 defensin pseudogenes. Several TATA box motifs were found for human
and mouse defensin genes that likely impact gene expression. Three novel defensin genes belonging to the
Cryptdin Related Sequences (CRS) family were identified. All additional mouse defensin loci on
Chromosomes 1, 2 and 14 were annotated and unusual splice variants identified. Comparison of the
mouse alpha-defensins in the three main mouse reference gene sets Ensembl, Mouse Genome Informatics
(MGI), and NCBI RefSeq reveals significant inconsistencies in annotation and nomenclature. We are
collaborating with the Mouse Genome Nomenclature Committee (MGNC) to establish a standardized
naming scheme for alpha-defensins.
Conclusions: Prior to this analysis, there was no reliable reference gene set available for the mouse strain
C57BL/6J defensin genes, demonstrating that manual intervention is still critical for the annotation of
complex gene families and heavily duplicated regions. Accurate gene annotation is facilitated by the
annotation of pseudogenes and regulatory elements. Manually curated gene models will be incorporated
into the Ensembl and Consensus Coding Sequence (CCDS) reference sets. Elucidation of the genomic
structure of this complex gene cluster on the mouse reference sequence, and adoption of a clear and
unambiguous naming scheme, will provide a valuable tool to support studies on the evolution, regulatory
mechanisms and biological functions of defensins in vivo.
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Background
Defensins are the largest family of cationic host defense
peptides in humans, and possess immunomodulatory
and direct antimicrobial activities [1]. In humans, alpha-
defensins are most abundant in neutrophils and Paneth
cells [2]. There are rare human disorders (Chediak Higashi
Syndrome and Specific Granule Deficiency) associated
with decreased or absent neutrophil alpha-defensins,
however other neutrophil granule components are also
deficient which makes it difficult to assign these disorders
to defensins themselves [3]. Loss or down regulation of
defensin genes is related to certain types of human cancer
[4-6]. Since murine neutrophils lack defensins [2,7],
Paneth cells provide an alternative to study alpha-
defensins in discrete compartments in a model organism,
the mouse, which has the largest known repertoire of
defensin-encoding sequences. The discovery of a mouse
Paneth cell defensin peptide, termed cryptdin (Defcr) due
to its expression in the Crypts of Lieberkühn [8], was the
first report of defensin expression in a non-myeloid cell
lineage [9,10]; Defcr was subsequently mapped to mouse
Chromosome 8 [11,12] and since has been discovered to
be part of a larger gene family including additional alpha-
defensin genes as well as cryptdin-related sequences
(CRS), also known as Defcr-rs (Defcr-related sequence).
This is due to their sequence similarity and genetic linkage
to Defcr [9-13]. Additional Defcr/Defcr-rs loci have been
discovered in different mouse strains, some of which may
be polymorphic and/or involved in copy number varia-
tion [11,14-17]. The confusion around gene names, vari-
able copy numbers and polymorphisms has made the
study of mouse defensins quite complex.
Defensin peptides are characterized by six canonical
cysteine residues at defined positions in the amino acid
sequence. The different spacing pattern between these
cysteines and the arrangement of the three disulphide
bonds that link them allow their further classification into
three subfamilies: alpha-, beta- and theta-defensins [18-
20]. Beta-defensins have a broad tissue expression pattern
and have been found across most vertebrates and some
invertebrate species, whilst alpha-defensins are specific to
certain mammals and are mainly produced by leukocytes
of myeloid origin and Paneth cells of the small intestine
[18-20]. Theta-defensins are believed to be derived by
cyclization of alpha-defensins and seem to be restricted to
the leukocytes of Old World monkeys [21].
Defensin genes have a characteristic two-exon structure,
and this is true for most mouse alpha-defensin genes.
However there are exceptions within the alpha-defensin
family, some of which have three exons. Members of the
beta-defensin family can have between two to four exons,
for example fish and birds have three-exon beta-defensins
[22]. However the differences between alpha- and beta-
defensins are most likely a consequence of gene duplica-
tion and subsequent divergence selected during evolution
[23]. Extensive analysis has provided insight into the evo-
lution of mammalian beta-defensins [23-25]. Alpha-
defensins are thought to have arisen by repeated gene
duplication of beta-defensins and positive diversifying
selection [23,26]. Therefore mouse Paneth cell alpha-
defensins have most likely "lost" one of these exons dur-
ing evolution and gene/chromosome duplication events
have led to their two exon structure. The high similarity of
mouse alpha-defensin genes and subsequent repetitive
nature of their chromosomal position lends support to
this model. As a rapidly evolving gene family, defensins
provide a useful system through which to study mamma-
lian evolution.
The nomenclature of mouse alpha-defensins is compli-
cated due to the duplicated nature of the genes. Problems
are encountered when mining genome databases
Ensembl, MGI and NCBI since there are multiple refer-
ences to individual gene names, making it difficult to
identify the actual annotated gene on the reference
sequence. The manual annotation presented here of the
defensin region on mouse Chromosome 8 addresses the
nomenclature issues for the alpha-defensins and collabo-
ration with the Mouse Genome Nomenclature Commit-
tee (MGNC) is helping to resolve these issues.
A collaborative effort was established between the Centre
for Microbial Disease & Immunity Research at the Univer-
sity of British Columbia (Vancouver, BC/Canada) and the
Wellcome Trust Sanger Institute (Hinxton, Cambridge/
UK) to investigate the genomic structure of alpha-
defensins and their functionality.
Results and Discussion
Genomic overview of the annotated region on mouse 
Chromosome 8
To fully characterize the defensin genes, we initially anno-
tated a genomic region on mouse Chromosome 8 consist-
ing of 18 finished BAC clones spanning 2.4 Mb of the
NCBI Build 36 assembly (and subsequently the Build 37)
reference sequence. To date this is the only known region
associated with alpha-defensins and was therefore chosen
as the initial starting point for defensin annotation in
mouse. Known MGI nomenclature was used to name
genes only if there was a 100% cDNA match. Otherwise
we referred to an interim Vega database identifier such as
OTTMUSG00000018259. The Vega database identifier is
stable, versioned and will remain unchanged after further
naming or assembly updates. MGNC has started assigning
symbols to most defensin pseudogenes identified here
and also implementing some of our suggestions concern-
ing nomenclature (Additional file 1: Supplemental Tables
S1&S2).BMC Genomics 2009, 10:606 http://www.biomedcentral.com/1471-2164/10/606
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This region contains three gaps of various sizes ranging
from 50 Kb to 2 Mb where additional/missing defensin
genes could be located (Figure 1A, map of the whole
region including gaps). Two beta-defensin gene clusters
flank the region containing the alpha-defensin genes. In
total, annotation of this genomic region revealed the
existence of 54 and 44 loci respectively in the alpha-
defensin and beta-defensin gene clusters (Additional file
1: Supplemental Tables S1&S2). The entire defensin gene
cluster is flanked by Xkr5 (X Kell blood group precursor-
related family, member 5) centromeric to Ccdc70 (coiled-
coil domain containing 70), Atp7b (ATPase, Cu++ trans-
porting, beta polypeptide) and Alg11 (asparagine-linked
glycosylation 11 homolog (yeast, alpha-1,2-mannosyl-
transferase)).
Beta-Defensin cluster
The mouse beta-defensin cluster contains 27 beta-
defensin genes, including sperm-associated antigen 11
(Spag11) and OTTMUSG00000020593 (Spag11c/h).
Spag11 genes encode beta-defensin-like peptides and have
shown tissue- and species-specific alternative splicing in
primate species [27]. Furthermore, three beta-defensin
pseudogenes and nine other pseudogenes as well as a gene
coding for a novel protein with tubby-like domains have
been annotated (Figure 1A). This manual annotation con-
firms the mouse beta-defensin repertoire reported in the
Overview of the defensin gene cluster region in mouse (top) and human (bottom) Figure 1
Overview of the defensin gene cluster region in mouse (top) and human (bottom). A clone tiling path is shown for 
the corresponding regions in mouse (top) and human (bottom). Clones are displayed in yellow but regions overlapping with 
adjacent clones are shown in black. Genes are indicated by arrows. Genes in shadowed boxes are duplicated and the color 
indicates the pairs; A -'- highlights all potential Defcr5 genes (see color legend for more details). The mouse assembly is based 
on NCBIM37, in which three gaps currently exist; two gaps are indicated by grey bars and the biggest gap between the two 
clusters is joined by a 'V'.
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most recent studies on mammalian beta-defensins
[24,28]. In the human genome most beta-defensin genes
have been recently duplicated but in the mouse genome
our manual annotation did not reveal any 100% identical
beta-defensin genes. This analysis is however limited by
the current mouse genome assembly in that we might not
have been able to see the most recent duplications. A very
recent publication indicates that a duplicated region is
missing in the current assembly [29]. Finishing of this
region might still reveal duplicated beta-defensin genes
similar to those in the alpha-defensin gene set (see
below).
Alpha-Defensin cluster
Twenty six apparently intact defensin-related cryptdin
genes and 22 related pseudogenes were observed within
the mouse alpha-defensin cluster (Figure 1 and 2A). Fur-
thermore six MYM-Type zinc finger protein pseudogenes
as well as three ribosomal protein pseudogenes are also
located in this region. Within the alpha-defensin gene
cluster there is a region containing several genes very sim-
ilar to Defcr5 but no identical match of the Swiss-Prot
entry P28312.2 for Defcr5, which is derived from the
genomic sequence of the 129 mouse strain. Two of these
loci, OTTMUSG00000019785 and
OTTMUSG00000018259 show only one amino acid dif-
ference in their signal peptides compared to the Defcr5
Swiss-Prot entry P28312.2 (Figure 3). Locus
OTTMUSG00000018258 shows one amino acid differ-
ence in its pro-segment to P28312.2 and locus
OTTMUSG00000019924 differs in one amino acid in the
signal peptide and one in the pro-segment compared to
P28312.2. These genes all have identical mature peptides
compared to the P28312.2 Defcr5 sequence and have
therefore been tagged as novel protein similar to defensin
related cryptdin 5. Questions arise as to whether a com-
mon sequence for the mature peptide qualifies these
genes to be named the same as a published sequence,
whether they have the same functionality and how differ-
ences in the signal- and/or pro-segment might affect their
expression. Consequently, these Defcr5 loci might be the
result of chromosomal duplications or involved in copy
number variation similar to a number of defensin genes
where we observed 100% identity throughout the entire
sequence (see below). Locus OTTMUSG00000019786
also has a best match to Defcr5 but there are three amino
acid differences, one in the signal peptide, one in the pro-
segment and another one in the mature peptide compared
to P28312.2. Therefore, this locus has been annotated as
a novel defensin related cryptdin without commenting on
any similarity to Defcr5, since there are clear precedents
for applying different names to defensins with small
sequence changes. In some cases 100% identical copies of
a gene were identified. One example of this is represented
by two copies for Defcr23. To clarify this situation we have
tagged one copy as Defcr23 and the other one as 'novel
defensin related cryptdin identical to Defcr23'. Two other
alpha-defensin genes, Defcr3 and Defcr20, have duplica-
tions in the mouse genome. Genes with duplicated copies
are ideal candidates for copy number variation.
Cryptdin-related sequences
Within the alpha-defensin gene cluster (Figure 1A) we
identified genes that show similarity to the prosegment of
the alpha-defensins but a different number and spacing
pattern of cysteines compared to any other known antimi-
crobial peptides [9,10,30]. Such genes are usually referred
to as cryptdin-related sequences (CRS). We have anno-
tated six genes belonging to two groups of cryptdin-
related sequences, CRS1C and CRS4C (Figure 2B) [13,30].
Nine cysteine residues characterize CRS peptides of the
CRS4C class found in the gastrointestinal mucosa [31];
CRS4C-6, annotated here OTTMUSG00000018344
belongs to the subfamily CRS4C; however, CRS4C-6,
which harbors ten cysteine residues has not been included
in prior studies [9,10,30]. Another cryptdin-related
sequence CRS1C-3 OTTMUSG00000019927, which is
located within the alpha cluster, is characterized by the
presence of 11 cysteines. An alpha-defensin-related
sequence  Defcr-rs, also known as CRS1C-2  and
OTTMUSG00000018260 which shows three amino acid
differences, one in the signal sequence and two in the
mature peptide, compared to Defcr-rs1
OTTMUSG00000019792, was also found in the alpha
gene cluster.
Two identical genes have been assigned as coding for
novel CRS1C peptides, OTTMUSG00000019859 and
OTTMUSG00000019893. All CRS1C peptides known to
date encode 116 amino acid proteins in contrast to alpha-
defensins that encode proteins with 93-95 amino acids. A
study on CRS4C peptides has shown that they form cova-
lent homo- and heterodimers, in vitro and in vivo, and are
potent at killing commensal and pathogenic bacteria, in
vitro[31]. Whether Defcr-rs1 (CRS1C-2) with its 11
cysteines has similar capabilities is unknown but it shares
all nine cysteines with members of the CRS4C family and
all ten with CRS4C-6.
We have tried to determine computationally whether any
members of the CRS family can be found in any other spe-
cies, rat in particular. Results can be viewed in Additional
file 1: Supplemental Tables S3&S4, Additional file 2: Sup-
plemental Information S1 and Additional file 3: Supple-
mental Figures S1&S2.
Identification of new splice variants within the mouse 
defensin genes
To complete the defensin gene set in mouse all other loci
on Chromosomes 1, 2 and 14 were also annotated. TheBMC Genomics 2009, 10:606 http://www.biomedcentral.com/1471-2164/10/606
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Multiple protein alignment of defensin peptides Figure 2
Multiple protein alignment of defensin peptides. Most defensin peptides contain six canonical cysteine residues (A); 
Members of the CRS1C family contain eleven cysteines in a different spacing between each other; CRS4C-6 belongs to the 
CRS4C family but consists of ten instead of the usual nine cysteines for this group (B). A novel sequence 
(OTTMUSG00000019857) has been annotated within the defensin gene cluster region which lacks all the canonical cysteines in 
any known number and spacing. Four cysteine residues can be found here but they don't align with any of the known cysteines 
in other peptides (C). All cysteine residues are highlighted in yellow. Genes identified for the first time in this study are tagged 
as noveldef.
(A) 
 
OTTMUSG00000019784(noveldef)   MKTLVLLSALFLLAFQVQADPIQKTDEETNTEVQPEEEEQAMSVSFGNPE 50 
Decfr26(OTTMUSG00000019889)   MKTLVLLSALFLLAFQVQADPIQNTDEETNTEVQPQEEDQAVSVSFGNPE 50 
Defcr25(OTTMUSG00000019700)   MKTLVLLSALALLAFQVQADPIQNRDEESKIDEQPGKEDQAVSVSFGDPE 50 
OTTMUSG00000019896(noveldef)   MKTLVLLSALALLAFQVQADPIQNRDEESKIDEQPGKEDQAVSVSFGDPE 50 
Defcr24(OTTMUSG00000019980)   MKTLILLSALVLLAFQVQADPIQNTDEETKTEEQPGEEDQAVSVSFGDPE 50 
OTTMUSG00000019742(noveldef)   MKTLILLSALVLLAFQVQADPIQNTDEETKTEEQPGEEDQAVSVSFGDPE 50 
Defcr3(OTTMUSG00000019782)   MKTLVLLSALVLLAFQVQADPIQNTDEETKTEEQPGEDDQAVSVSFGDPE 50 
OTTMUSG00000019892(Defcr3dupl)        MKTLVLLSALVLLAFQVQADPIQNTDEETKTEEQPGEDDQAVSVSFGDPE 50 
Defcr23(OTTMUSG00000019488)           MKTLVLLSALILLAFQVQADPIQNTDEETKTEEQPGKEDQAVSVSFGDPE 50 
OTTMUSG00000019762(Defcr23dupl)       MKTLVLLSALILLAFQVQADPIQNTDEETKTEEQPGKEDQAVSVSFGDPE 50 
OTTMUSG00000019785(novelDefcr5)       MKTFVLLSALVLLAFQAQADPIHKTDEETNTEEQPGEEDQAVSISFGGQE 50 
OTTMUSG00000018258(novelDefcr5)       MKTFVLLSALVLLAFQVQADPIHKTDEETNTEEQPGEEDQAVSISFGGQE 50 
OTTMUSG00000018259(novelDefcr5)       MKTFVLLSALVLLAYQVQADPIHKTDEETNTEEQPGEEDQAVSISFGGQE 50 
OTTMUSG00000019924(novelDefcr5)       MKTIVLLSALVLLAFQVQADPIQKTDEETNTEEQPGEEDQAVSISFGGQE 50 
OTTMUSG00000019786(noveldef)          MKTFVLLSALVLLAFQAQADPIHKTDEETNTEEQPGEEDQAVSISSGGQE 50 
Defcr21(OTTMUSG00000019489)           MKTLVLLSALILLAYQVQTDPIQNTDEETNTEEQPGEDDQAVSVSFGGQE 50 
OTTMUSG00000019763(noveldef)          MKTLVLLSALILLAYQVQTDPIQNTDEETNTEEQPGEEDQAVSVSFGGQE 50 
Defcr20(OTTMUSG00000019856)           MKTLVLLSALVLLAFQVQADPIQNTDEETNTEEQPGEEDQAVSVSFGDPE 50 
OTTMUSG00000019860(Defcr20dupl)       MKTLVLLSALVLLAFQVQADPIQNTDEETNTEEQPGEEDQAVSVSFGDPE 50 
                                ***::***** ***:*.*:***:: ***:: : ** :::**:*:* *. * 
 
OTTMUSG00000019784(noveldef)         GSDLQEES---LRDLGCYCRKRGCTRRERINGTCRKGHLMYTLCCL----- 93 
Decfr26(OTTMUSG00000019889)          GSDLQEES---LRDLGCYCRKRGCTRRERINGTCRKGHLMYTLCCL----- 93 
Defcr25(OTTMUSG00000019700)           GSSLQEEC----EDLICYCRTRGCKRRERLNGTCRKGHLMYMLWCC----- 92 
OTTMUSG00000019896(noveldef)   GSSLQEESSSALRDRICYCRTS-CKKRERLNGTCRKGHLMYKLCCR----- 95 
Defcr24(OTTMUSG00000019980)          GASLQEES---LRDLVCYCRARGCKGRERMNGTCSKGHLLYMLCCR----- 93 
OTTMUSG00000019742(noveldef)          GSSLQEES---LRDLVCYCRARGCKGRERMNGTCSKGHLMYMLCCR----- 93 
Defcr3(OTTMUSG00000019782)            GSSLQEES---LRDLVCYCRKRGCKRRERMNGTCRKGHLMYTLCCR----- 93 
OTTMUSG00000019892(Defcr3dupl)        GSSLQEES---LRDLVCYCRKRGCKRRERMNGTCRKGHLMYTLCCR----- 93 
Defcr23(OTTMUSG00000019488)           GSSLQEES---LRDLVCYCRTRGCKRRERMNGTCRKGHLIYTLCCR----- 93 
OTTMUSG00000019762(Defcr23dupl)  GSSLQEES---LRDLVCYCRTRGCKRRERMNGTCRKGHLIYTLCCR----- 93 
OTTMUSG00000019785(novelDefcr5)       GSALHEEL---SKKLICYCRIRGCKRRERVFGTCRNLFLTFVFCCS----- 93 
OTTMUSG00000018258(novelDefcr5)       GSALHDEL---SKKLICYCRIRGCKRRERVFGTCRNLFLTFVFCCS----- 93 
OTTMUSG00000018259(novelDefcr5)       GSALHEEL---SKKLICYCRIRGCKRRERVFGTCRNLFLTFVFCCS----- 93 
OTTMUSG00000019924(novelDefcr5)       GSALHEEL---SKKLICYCRIRGCKRRERVFGTCRNLFLTFVFCCS----- 93 
OTTMUSG00000019786(noveldef)          GSALHEEL---SKKLICYCRIRGCKRRECVFGTCRNLFLTFVFCCS----- 93 
Defcr21(OTTMUSG00000019489)           GSALHEKL---SRDLICLCRNRRCNRGELFYGTCAGPFL---RCCRRRR-- 93 
OTTMUSG00000019763(noveldef)          GSALHEKL---SRDLICLCRKRRCNRGELFYGTCAGPFL---RCCRRRR-- 93 
Defcr20(OTTMUSG00000019856)           GSALHEKS---SRDLICYCRKGGCNRGEQVYGTCSGRLL---FCCRRRHRH 95 
OTTMUSG00000019860(Defcr20dupl)       GSALHEKS---SRDLICYCRKGGCNRGEQVYGTCSGRLL---FCCRRRHRH 95 
                                *: *:::     ..  * **   *.  * . ***    *     *      
 
 
 
(B) 
 
Defcr-rs1(OTTMUSG00000019792)      MKTLVLLSALVLLAFQVQADPIQNTDEETKTEEQPEEEDQAVSVSFGGTE 50 
OTTMUSG00000018260(novelCRS1C)       MKTLVLLSALALLAFQVQADPIQNTDEETKTEEQPEEEDQAVSVSFGGTE 50 
OTTMUSG00000019927(CRS1C-3)         MKTLVLLSALALLAFQVQADPIKNTDEETKTGEQPEEEDQAVSVSFGGTE 50 
OTTMUSG00000019893(novelCRS1C)      MKTLVLLSALALLALQVQADPIQNTDEETKTQEQPGEEDQAVSVSFGGTE 50 
OTTMUSG00000019859(novelCRS1C)       MKTLVLLSALALLALQVQADPIQNTDEETKTQEQPGEEDQAVSVSFGGTE 50 
OTTMUSG00000018344(CRS4C-6)          MKTLVLLSALVLLAFYVQADSTQETDEETKTDDQPGEEDQGVSVSFEDPE 50 
                               **********.***: ****. ::******* :** ****.***** ..* 
 
Defcr-rs1(OTTMUSG00000019792)       GSALQDVAQRRFPWCRKCRVCQKCQVCQKCPVCPTCPQCPKQPLCEERQN 100 
OTTMUSG00000018260(novelCRS1C)       GSALQDVAQRRFLWCRKCPVCQKCQVCQKCPVCPTCPQCPKQPLCEERQN 100 
OTTMUSG00000019927(CRS1C-3)         GSALQYVAQRRFPWCRKCPVCQKCQVCQKCPVCPTCPQCPKLPLCKERQN 100 
OTTMUSG00000019893(novelCRS1C)      GSALQDVAQRRFPWCRKCRVCQKCEVCQKCPVCPTCPQCPKQPLCKERQN 100 
OTTMUSG00000019859(novelCRS1C)       GSALQDVAQRRFPWCRKCRVCQKCEVCQKCPVCPTCPQCPKQPLCKERQN 100 
OTTMUSG00000018344(CRS4C-6)             RYVLQVSGLGKPPQCPKCPVCSKCPQCPQCPQCPGCPRCN----CMTK-- 94 
                               .**  .  :   * ** **.**  * :** ** **:*     *  :   
 
Defcr-rs1(OTTMUSG00000019792)    KTAITTQAPNTQHKGC 116 
OTTMUSG00000018260(novelCRS1C)       KTAITTQAPNTQHKGC 116 
OTTMUSG00000019927(CRS1C-3)         KSAITTQAPNTQHKGC 116 
OTTMUSG00000019893(novelCRS1C)      KTAITTQAPNTHHKGC 116 
OTTMUSG00000019859(novelCRS1C)       KTAITTQAPNTHHKGC 116 
OTTMUSG00000018344(CRS4C-6)          ---------------- 
 
 
 
 
(C) 
 
OTTMUSG00000019857(noveldef)        MKTLVLLSALALLAFQVQADPIQNRDEESKIDEQPGKEDQAVSVSFGDPE 50 
  
 GSSLQEECEDRICYCRTSCKKKRTPDWDLQKGSFNVQALLPLNMETTEDK  98 
  
  TAMSTEATDAGA 112 BMC Genomics 2009, 10:606 http://www.biomedcentral.com/1471-2164/10/606
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beta-defensin cluster on Chromosome 2 consisting of 11
gene loci is the largest among them. Interestingly, novel
splice variants were annotated for Defb30 and Defb42 on
Chromosome 14, which is in contrast to the family mem-
bers on Chromosome 8. Defb30 has four different splice
variants, one of which was previously known; three vari-
ants have been tagged as "putative coding" as they have a
different first exon compared to the known variant. Two
pairs of variants share the same 5' exon but differ in the 3'
exons. In each pair, one variant consists of three exons and
the other one of two (Figure 4). For Defb42 two coding
and two non-coding variants have been identified and
annotated. One of the transcripts that seems to lack cod-
ing properties has been tagged as a transcript likely to be
subject to nonsense-mediated mRNA decay (NMD). All
four  Defb42  variants have differentially spliced 5' first
exon and only one has previously been known in other
gene sets. Tissue-specific and species-specific alternative
splicing has been previously shown for primate SPAG11
[27]. The beta-defensin Defb42 has been discovered and
characterized in mice and its expression has been shown
to be epididymis-specific [32]. Looking at the origin of the
manually annotated spice variants for Defb42 it is notice-
able that all cDNA clones representing the main coding
variant are derived from the adult male reproductive tract,
specifically the epididymis. However, there is one coding
cDNA with an alternative 5' UTR exon compared to the
main variant that has been derived from the spleen of a
four week old male mouse. The potential NMD splice var-
iant is a two cells egg cDNA and another overlapping non-
coding transcript is based on an 11 days embryo whole
body cDNA. This observation suggests that alternative
splicing for Defb42 is likely to be also development stage
specific. An unusual feature was observed for Defb17 and
Defb41 on Chromosome 1. These genes share the same
start and first exon but differ in their second exon, which
is crucial since it encodes the mature peptide. According to
our general annotation guidelines these two genes would
normally be merged and the two transcripts would repre-
sent splice variants of the same gene since they share the
first coding exon. Differential splicing seems to be a rare
event for defensin genes; however, the observed examples
here indicate the potential functional differences for the
affected transcripts.
Genomic structures of annotated defensins on 
Chromosome 8
A) TATA Boxes
Annotation of TATA boxes has been based on motifs veri-
fied experimentally and published previously for five
defensin genes in mouse [14,15] and two defensin genes
in human [33]. We suggest the position of TATA box
motifs for several more defensin genes (26 in total) by
manual annotation of this gene cluster in mouse (Figure
5 and Additional file 1: Supplemental Table S1) with
duplicated defensin genes having the same TATA box
sequence. However, for some loci no TATA box could be
defined based on the known consensus. For a novel
alpha-defensin gene, OTTMUSG00000019784, and for
Defcr26 a TATA box with a weaker consensus was identi-
fied (Figure 5) which may affect the expression of these
genes. An experimental verification would be necessary to
find out whether this motif is active and if so to what
extent. It is known that TATA box containing genes are sig-
The polymorphic Defcr5 locus Figure 3
The polymorphic Defcr5 locus. A protein alignment between all potential Defcr5 copies and P28312.2. Variation in amino 
acids is highlighted in red.
 
P28312|DEF5_mouse   MKTFVLLSALVLLAFQVQADPIHKTDEETNTEEQPGEEDQAVSISFGGQE  50 
OTTMUSG00000019785   MKTFVLLSALVLLAFQAQADPIHKTDEETNTEEQPGEEDQAVSISFGGQE 50 
OTTMUSG00000018258   MKTFVLLSALVLLAFQVQADPIHKTDEETNTEEQPGEEDQAVSISFGGQE  50 
OTTMUSG00000018259   MKTFVLLSALVLLAYQVQADPIHKTDEETNTEEQPGEEDQAVSISFGGQE 50 
OTTMUSG00000019924   MKTIVLLSALVLLAFQVQADPIQKTDEETNTEEQPGEEDQAVSISFGGQE 50 
                            ***:**********:*.*****:*************************** 
 
P28312|DEF5_mouse   GSALHEELSKKLICYCRIRGCKRRERVFGTCRNLFLTFVFCCS  93 
OTTMUSG00000019785   GSALHEELSKKLICYCRIRGCKRRERVFGTCRNLFLTFVFCCS  93 
OTTMUSG00000018258   GSALHDELSKKLICYCRIRGCKRRERVFGTCRNLFLTFVFCCS 93 
OTTMUSG00000018259   GSALHEELSKKLICYCRIRGCKRRERVFGTCRNLFLTFVFCCS  93 
OTTMUSG00000019924   GSALHEELSKKLICYCRIRGCKRRERVFGTCRNLFLTFVFCCS  93 
                            *****:************************************* 
Signal peptide  Pro-peptide 
Mature peptide BMC Genomics 2009, 10:606 http://www.biomedcentral.com/1471-2164/10/606
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nificantly more likely to change in expression and are
biased towards spontaneous mutations [34]. Three genes
in the beta-defensin region (Defb12, Defb51 and Defb33)
and a defensin-related gene (Spag11c/h) show a three-
exon structure and the gene Defb52 consists of four exons
in contrast to all the other defensin genes with two exons.
A TATA box could only be identified for one of them,
Defb12, with a consensus identical to the main TATA box
motif in this region. In the human cluster, the annotation
of TATA box motifs revealed the existence of one motif
(TTAAATA) that has not been identified in mouse.
Several TATA box-less genes (Defcr25,
OTTMUSG00000019857 and OTTMUSG00000019896)
and also two pseudogenes (OTTMUSG00000019793 and
OTTMUSG00000019923) have an identical 5' UTR/pro-
moter region to that of previously reported 'Crypi'
[14,15], which is presumed to be non-functional because
of a pre-mature stop codon. The question that arises is
whether these loci represent new pseudogenes or whether
their expression is regulated by an alternative promoter.
The gene OTTMUSG00000019857 has a divergent C-ter-
minus/mature peptide compared to all other defensin
genes (Figure 2C). It has a coding potential for 112 amino
acids but three of the consensus cysteine residues are miss-
ing. These data suggest that this gene is possibly pseudog-
enic in the reference genome, C57BL/6J.
B) Pseudogenes
A total of 22 defensin pseudogenes were annotated in the
major mouse defensin gene cluster region on mouse
Chromosome 8 (Additional File 1: Supplemental Table
S2), while ten pseudogenes were annotated in the corre-
sponding human defensin cluster. It has been shown that
~10% of the pseudogenes annotated in the Encyclopedia
of DNA Elements (ENCODE) project are from genes
involved in the immune response [35], thus the high fre-
quency of defensins pseudogenes (>25%) is notable.
We divide pseudogenes into two categories, processed and
unprocessed, with two subcategories each, transcribed or
untranscribed. A locus is annotated as pseudogene when
clear homology is shown to proteins but the coding
sequence is disrupted, resulting in frameshifts or in-frame
Novel coding and non-coding variants Figure 4
Novel coding and non-coding variants. Vega presenting the region for Defb30 and Defb42, where three new variants per 
locus were annotated. Defb30: Variants 1 is a known variant with known CDS, variant 2 is a novel variant with the same CDS 
as variant 1 but has an alternative 3' UTR, variant 3 and 4 are novel variants with putative CDS and different 3'UTR. Defb42: 
Variant 1 represents a non-coding transcript, variant 2 is a novel variant with the same CDS as the known transcript (3) but 
with an alternative 5' UTR, variant 3 is a known variant with known CDS and variant 4 is a NMD candidate.
 BMC Genomics 2009, 10:606 http://www.biomedcentral.com/1471-2164/10/606
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stop codons. A locus can also be tagged as a pseudogene
when one or more parent genes that show spliced gene
structure can be found elsewhere in the genome while the
pseudogene locus looks like a single exon encoding for
the corresponding protein.
Pseudogenes of the defensin gene cluster are unprocessed
as they have likely evolved through duplication of func-
tional genes and have accumulated mutations over time
and become non-functional. Of the 22 pseudogenes
annotated in this region five are only partial and one,
Defa-ps1  has been tagged as transcribed_unprocessed
pseudogene. Here, protein homologies point to this locus
being a pseudogene, but overlapping locus-specific tran-
scription evidence (cDNAs) indicates expression. There is
recent evidence that regulatory interdependency exists
between transcribed pseudogenes and their parent gene.
For example a targeted knockdown of the transcribed ABC
transported pseudogene ABCC6P1 results in a significant
reduction of the parent gene ABCC6  expression levels
[36]. As an ongoing collaboration between our group and
the MGNC, a list of annotated pseudogenes has been sent
to MGNC and symbols have been already assigned to
some of them (Additional file 1: Supplemental Table S2).
We have also looked at the 5' upstream genomic
sequences of defensin related pseudogenes to look for
TATA box-like motifs. There are two defensin pseudo-
genes where a strong TATA box motif (TATAAA TG) could
be found and four pseudogenes with a weak TATA box
motif (TATACA TA/G), but for the majority nothing simi-
lar could be identified. Looking at the transcribed pseudo-
gene, Defa-ps1, the homology breaks 48 bp upstream of
the start codon and no TATA box-like motif could be iden-
tified. Generally, the TATA box-lacking defensin pseudo-
genes have 5' sequences similar to the potential promoter
regions of TATA box-lacking active defensin genes.
Comparative Analysis of Gene Sets
To illustrate the difficulties created in naming the
defensins, by comparison to the assembled data from
databases and the literature, we have cross-referenced four
major gene sets and assembled gene symbols and gene
IDs for the mouse alpha-defensin genes annotated herein
(Additional file 1: Supplemental Table S5). These include
our manually curated data set from Vega v.30, automatic
gene annotation from Ensembl v.49, cDNA evidence from
NCBI RefSeq, and a merged gene set encompassing UCSC,
RefSeq and Ensembl from MGI 4.01 [37]. The gene
Defcr25 has a cross-reference to gene Defcr2 in NCBI's Ent-
rez Gene indicating that this gene is also known as Defcr2.
However, the protein sequences for Defcr25
(MGI:3630385; Swissprot:Q5G864.1) and Defcr2
(MGI:94882; Swissprot:P28309.2) are different and are
derived from different mouse strains. Therefore, we have
annotated the locus as Defcr25, since the sequence in the
reference mouse genome is identical to this gene. Another
example of ambiguities between databases are Defcr16
and Defcr17, which have been associated by MGI with
OTTMUSG00000019742 and OTTMUSG00000019892
Potential promotor region for some defensin genes Figure 5
Potential promotor region for some defensin genes. (A) For two genes OTTMUSG00000019784 and Defcr26 a weak 
TATA box motif could be identified. (B) A strong TATA box motif was found for 27 defensin genes, here an example is shown 
for Defcr3 and OTTMUSG00000019785, a novel defensin gene. TATA box motifs are shown in red/blue and start codons in 
green.
(A) 
 
OTTMUSG00000019784 CTTTTCTCTGCCATATACATATGGGCTGACTAATCACACTCCACACATTGGGCTCCTGTT 60 
Defcr26(OTTMUSG00000019889) CTTTTCTCTGCCATATACATATGTGCTGACTAATCACACTCCACACATTGGGCTCCTGCT 60 
                     *********************** ********************************** * 
 
OTTMUSG00000019784 CCCCAATCCCCCAGGTGACTCCCAGCCATG 90 
Defcr26(OTTMUSG00000019889)    CCCCAATCCCCCAGGTGACTCCCAGCCATG 90 
                         ****************************** 
(B) 
 
Defcr3(OTTMUSG00000019782)       CCTTTCTCTGTCCTATAAATGCAGGCTGGATATTCACTCTCCACACATTGGGCTCCTGCT 60 
OTTMUSG00000019785 CCTTTCTCTGCCCTATAAATGCAAGTTGGCTACTCACTCTCCACACATTGGGCTCCTGCT 60 
                    ********** ************ * *** ** *************************** 
 
Defcr3(OTTMUSG00000019782)       CACCAATCCTCCAGGTGACTCCCAGCCATG 90 
OTTMUSG00000019785 CAACAATTCTCCAGGTGACCCCCAGCCATG 90 
 ** **** *********** ********** BMC Genomics 2009, 10:606 http://www.biomedcentral.com/1471-2164/10/606
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respectively; in case of Defcr16 evidence for its expression
is derived from C3H/HeJ strain only and the association
of  Defcr17  with the Vega model is incorrect as
OTTMUSG00000019892 is a duplicate of Defcr3. Addi-
tional examples are listed in the Additional file 1: Supple-
mental Table S5.
This analysis has highlighted the necessity in accounting
for strain differences when deriving gene annotation
based on cDNAs aligned to the C57BL/6 reference
genome. The differences become very obvious when look-
ing at the alpha-defensin region in MGI Genome Browser
(Additional file 3: Supplemental Figures S3&S4). The
number of alpha-defensin genes here is higher than the
number annotated by our group but looking at the origin
of many of the genes reveals that they are derived from
strains distinct from the reference genome. An example is
the Crp4 peptide, which was first isolated from Outbred
Swiss mice [38] and corresponds to Defcr4 in MGI; this
gene has been annotated on the 129X1/SvJ strain but has
not been annotated on the reference strain (Additional
file 1: Supplemental Table S6). The reference strain con-
tains two presumed Crp4 peptide variants termed Crp4-
B6a and Crp4-B6b because they are all missing three
codons between the forth and fifth cysteine residues [39].
MGNC has named these variants Defcr20 and Defcr21,
respectively; however the relationship of these peptides
between the two mouse strains is not obvious.
Data displayed in MGI's GBrowse is a combination of
down loaded information from the UCSC's Genome
browser [40] and that generated at MGI. MGI and UCSC
do not filter any strain-specific data and mapping of
defensin genes has not been carried out stringently with
the aim of displaying a comprehensive set of all existing
genes. This is a valuable resource, however, as a result sev-
eral genes which share the same nucleotide sequence cod-
ing for the signal peptide and the pro-segment have been
mapped together. However, as the region encoding the
mature peptide shows some differences these genes can-
not be considered the same.
To determine the ease of cross-species comparison,
genomic alignments and putative orthologues were
searched for in both human and rat genomes compared to
mouse alpha-defensins. There are only six defensin genes
with defined orthologues between human and mouse
found on the Mouse Chromosome 8 Linkage Map [41].
We appreciate that for the mouse alpha-defensin family,
orthology is especially hard to predict because of the high
intraspecies similarity for these genes. The same human
and rat genes align with most of the mouse genes and/or
are predicted to be orthologues for the mouse peptides. In
particular, DEFA7P is predicted to be the human ortho-
logue for the majority of the mouse cryptdins by Ensembl
but this gene lacks a start codon [23] and has therefore
been designated a pseudogene by manual annotation.
These alignments and orthologues have been predicted by
Ensembl and may be an artefact of their naming scheme.
We also examined the human and rat genome assemblies
and compared a region of conserved synteny relative to
the mouse genome (Additional file 2: Supplemental
Information S2).
Since defensin genes are involved in copy number varia-
tion as well as they reveal polymorphisms between strains
and a one to one orthology between different species is
hard to predict, it is crucial to work out a standardized sys-
tem that can be followed by all genome browsers to indi-
cate these important differences. As a first step towards
this solution we propose a reorganization of the nomen-
clature of the mouse alpha-defensins.
Time to update the defensin naming scheme?
Consistency and standardization in naming genes is often
an issue between research groups, journals and genome
browsers. Additional file 1: Supplemental Table S7 gives
an overview of the defensin naming in various species,
which highlights these discrepancies. This is very obvious
in the case of the defensin genes in mouse and is most
likely due to a combination of factors. Defensins were first
discovered as peptides or from cDNA. With the comple-
tion of large-scale genome sequencing projects, it has
become possible to mine these genomes for defensin
genes by scanning translated genomic sequence for the six
conserved cysteine residues. Some defensins have only
been identified at the genomic level without subsequent
peptide or RNA expression data. Searching the literature
gives the impression that the naming of cryptdins is
orderly and systematic however searching major data-
bases for the corresponding information is difficult. The
problem arises because most of the experimental data
comes from mouse strains different to the C57BL/6J refer-
ence genome. We have found evidence to confirm that
there are strain and CNV differences within the defensin
gene family and therefore annotating/mapping genes and
peptides discovered in non-reference strains remains a
challenge.
A recent report has reviewed the nomenclature for chicken
defensins, also known as 'gallinacins', and proposed their
standardized renaming as a result of confusion in the lit-
erature from the employment of multiple naming
schemes by different groups [42]. Currently, the naming
for beta-defensins in avians is very heterogeneous (e.g.
'ostricacins' for ostrich beta-defensins) and a system has
been proposed that involves renaming genes as part of an
adaptation to the new system for avian beta-defensins in
which the term "avian beta-defensin", abbreviated to
AvBD, has been suggested [42].BMC Genomics 2009, 10:606 http://www.biomedcentral.com/1471-2164/10/606
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Here we propose a similar reconsideration of mouse, rat
and human defensins with the aim of a standardized
naming scheme agreed on by the corresponding nomen-
clature committees, MGNC/RGNC/HGNC, which we
hope will be adopted by the major genome centres, jour-
nals and genome browsers so that results from various
research studies can be compared easily and efficiently.
We also propose that the naming scheme should be appli-
cable to all organisms. For human, mouse and many other
species, the abbreviation DEFB/Defb and DEFA/Defa has
been used to tag beta- and alpha-defensins, respectively.
Both HGNC and MGNC groups have approved the DEFB/
Defb and DEFA/Defa naming schemes for human and
mouse [43]. We propose the continuation of the latter sys-
tem as otherwise a taxonomy-based naming would
become complicated; therefore we have sent our sugges-
tions for a clearer and unified naming scheme to MGNC.
The change of the Defcr root to Defa has already been
implemented for mouse alpha-defensins. We propose
that the naming scheme should also take into considera-
tion relationships between peptides in different strains of
mice (e.g. as shown for Crp4).
Since alpha-defensins are being found in species outside
of the Euarchontoglires branch of mammals [44], it is cru-
cial to establish a standardized nomenclature system. Also
the existence of CNV in defensin genes, and of genes with
highly related sequences, adds to the complexity of devel-
oping a consistent and meaningful naming scheme.
Conclusions
The investigation of mouse alpha-defensins is difficult
due to the duplicated nature of the genes and the resulting
gaps within the reference genome assembly of the alpha-
defensin region of mouse Chromosome 8. Knocking out
multiple endogenous defensins, including alpha-
defensins, in mice may provide a direct indication of their
function and also address the issue of redundancy; how-
ever difficulties in characterizing mouse alpha-defensins
has hindered this research. Designing unique primers for
individual knockout of alpha-defensin genes is impossi-
ble and the exact complement of the alpha-defensin genes
within the mouse reference genome (C57/BL6 strain) is
still unknown. The recent formation of the Genome Ref-
erence Consortium [45] should contribute to gap closure
in important regions such as the alpha-defensin on Chro-
mosome 8 and aid identification of the complete defensin
repertoire for the reference mouse genome. Detection of
copy number variation and structural variation in mouse,
similar to what has been observed in human (Additional
file 2: Supplemental Information S3) has proven to be dif-
ficult because of the limited sequence information on var-
ious mouse strains and as well the presence of the 2 Mb
gap in Chromosome 8. This gap has the potential to be
collapsed due to the highly repetitive nature of the genes
in this region but also if there is a larger scale duplication.
Current mouse tile-path arrays do not have the capability
to resolve individual gene copy numbers and their design
is limited by the current mouse genome assembly. Genes
that we have annotated as 100% identical are obvious
candidates for copy number variants but sequence infor-
mation from additional mouse strains is needed for this
verification. Between the existing alpha-defensins we have
observed apparent polymorphisms in different mouse
strains. A project undertaken at the Sanger Institute aims
to sequence the genomes of 17 common mouse strains,
but it is reasonable to assume that there will be difficulties
in assembling Chromosome 8 proximal to regions con-
taining alpha-defensin genes. However comparisons
between sequence available for these strains will start to
define the copy number and polymorphic variation of
mouse alpha-defensins.
The manual annotation of the defensin gene cluster ena-
bled not only the identification of many pseudogenes pre-
viously unknown in this region, but also the identification
of novel defensin genes and defensin-related sequences
belonging to the CRS family with a different cysteine
arrangement. The experimental validation to confirm if
these proteins are functional is yet to be done.
At present only a small fraction of the annotated genes
have peptide products that have been purified. The small
size, redundancy and variable expression levels of these
peptides may be the reasons for the difficulty in isolating
the peptides. Transcriptional profiling will enable the
identification of expressed genes, however sophisticated
methods will be necessary to distinguish between and
quantify these highly similar transcripts. Additionally it
can be determined whether expression correlates with the
promoter region for each gene, i.e. the presence of a TATA
box, CpG island or novel motif. This will allow for the
separation of the roles of each unique defensin in normal
immune function as well as during infection or inflamma-
tion.
Evolution, duplication and allelic variation of defensin
genes are currently under investigation [46-48]. Since
many diseases/disorders appear to be modulated by copy
number variation, the review and standardization of CNV
nomenclature is critical to future studies.
Methods
Analysis and Annotation pipeline
Prior to the process of manual annotation an automated
analysis for similarity searches and ab initio predictions is
run in an extended Ensembl analysis pipeline system [49].
All search results are stored in an Ensembl MySQL data-
base. Following genomic sequence masking of inter-
spersed repeats and tandem repeats by RepeatMasker andBMC Genomics 2009, 10:606 http://www.biomedcentral.com/1471-2164/10/606
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Tandem repeats finder [50], a search with wuBLASTN
against the nucleotide databases starts. Significant hits are
then re-aligned to the unmasked genomic sequence using
est2genome [51]. The Uniprot protein database is then
searched with wuBLASTX. In order to provide prediction
of protein domains Genewise [52] is used to align hidden
Markov models for Pfam protein domains against the
genomic sequence. Finally, a number of different ab initio
algorithms are used: Genescan [53] for genes, tRNAscan
[54] to find tRNA genes and Eponine TSS [55], to predict
transcription start sites.
After completion of the automated analysis, manual
annotation starts using a Perl/Tk based graphical inter-
face, called 'otterlace', developed in-house to edit annota-
tion data stored in a separate MySQL database system
[56]. It provides different tools for changing exon coordi-
nates, adding gene names and remarks, assigning genes to
different categories or adding genomic features such as
poly(A) sites and signals. The annotation of gene objects
requires a visual representation of the genomic region and
features like CpG islands, repeats and poly(A) sites, gene
predictions, evidence which support the annotation of
gene structures (ESTs/cDNAs/proteins) and all transcript
variants created by annotators. This representation is pro-
vided by a graphical user interface called ZMap which was
written in C to give the high performance required to dis-
play large numbers of features (Storey, personal commu-
nication). An alignment viewer called 'Blixem' [57] allows
gapped alignments of nucleotide and protein blast hits to
be compared with the genomic sequence. Furthermore, a
'Dotplot' tool called 'Dotter' [57] is used to show pair-wise
alignments of unmasked sequences, revealing the loca-
tion of exons that are occasionally missed by the auto-
mated blast searches because of their small size and/or
match to repeat-masked sequence.
All annotation is publicly available in the Vertebrate
Genome Annotation (VEGA) browser. Definitions of Vega
gene and transcript types can also be found on the website
http://vega.sanger.ac.uk/index.html. Since the first anno-
tation of the region was performed the assembly has
changed slightly and some of the gene names have been
changed. Figure 1 represents the most current situation
and Vega will be updated accordingly.
Mouse genomic assembly
This manual annotation of the defensin gene cluster
region was based on NCBI Build 36. However, at the time
of the writing the new build NCBIM37 has been released
and the two assemblies show several differences. The most
crucial one is that a new clone AC161189 has been added
to the new assembly which overlaps partially with and has
replaced clone AC140205. Although most genes initially
annotated in AC140205 are present in AC161189, there
are seven loci missing. One of these codes for beta-
defensin 33 (Defb33) and the remaining ones are different
pseudogenes. In order to preserve this data we propose
that the clone AC140205 should be trimmed from the
point where it is unique and be returned to the new
assembly. The Genome Reference Consortium [45],
which is a collaborative effort between NCBI, the Sanger
Institute, EMBL-EBI and the Genome Center at Washing-
ton University, aim to close remaining gaps in the human
and mouse genomes and remove discrepancies in clones
observed by research groups. The issue described here has
been submitted to the Consortium.
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